JANX - Janux Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
25.8 2.7 (10.45%)	---	---	0.0 (0.0%)	---	2.49 (9.65%)	0.2 (0.7%)	0.2 (0.7%)

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.55
Diluted EPS:: -0.55
Basic P/E:: -51.8125
Diluted P/E:: -51.8125
RSI(14) 1m:: 100.0
VWAP:: 28.5
RVol:: 1.9486

Events

Period	Kind	Movement	Occurred At
Day	Price increase day	28.5 +2.7 (+10.45%)	Oct 15 19:04
1m	Price increase 1m	27.31 +0.32 (+1.2%)	Oct 15 13:02
1m	Price increase 1m	27.43 +0.32 (+1.16%)	Oct 15 10:09
10m	Price increase 10m	27.43 +0.83 (+3.12%)	Oct 15 10:09
1m	Price increase 1m	26.99 +0.45 (+1.71%)	Oct 15 10:02